Success Stories: Dual Victory in Pharmaceutical Sciences – NIW and EB1A Approvals Secured
Client’s Testimonial:
“Thank you for your quick actions and Guidance from the Beginning to the End.”
On May 17th, 2024, and April 12th, 2025, we received another EB-2 NIW (National Interest Waiver) and EB1A (Alien of Extraordinary Ability) approvals for a Scientist III, Research & Development in the field of Pharmaceutical Sciences (Approval Notice).
General Field: Pharmaceutical Sciences
Position at the Time of Filing: Scientist III, Research Read more [...]